Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of TYRA-300-B01 tablets in patients with low grade, intermediate risk non-muscle invasive bladder cancer who have FGFR3 gene changes

    Recruiting

    1 1
    Investigated drugs:
    France Italy Spain
  • Study of MK-3120 for patients with high-risk non-muscle invasive bladder cancer who have not received or have received BCG treatment

    Recruiting

    1 1
    Investigated drugs:
    Austria Belgium France Greece Italy The Netherlands +2
  • A study comparing erdafitinib delivery system to chemotherapy for patients with high-risk non-muscle-invasive bladder cancer who received BCG treatment

    Recruiting

    1 1 1 1
    Investigated diseases:
    Belgium France Germany Greece Italy The Netherlands +1
  • Study of nadofaragene firadenovec alone or with gemcitabine, docetaxel or pembrolizumab in adults with non-muscle invasive bladder cancer who did not respond to BCG therapy

    Recruiting

    1 1 1 1
    Investigated diseases:
    Czechia Denmark France Poland Spain
  • Study of Nadofaragene Firadenovec for Adults with Intermediate Risk Non-Muscle Invasive Bladder Cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Denmark France Italy Poland Spain
  • Study on the Effectiveness and Safety of Mitomycin C with Electric Current for Treating Non-Muscle Invasive Bladder Cancer in Patients, Compared to Standard Immunotherapy

    Recruiting

    1 1 1 1
    Investigated drugs:
    Spain
  • Study on Mitomycin and BCG for Patients with Recurrent Non-Muscle Invasive Bladder Cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Denmark Iceland Norway Sweden
  • Study on Hexaminolevulinate for Patients with Non-Muscle Invasive Bladder Cancer to Reduce Need for Second Surgery

    Recruiting

    1 1 1 1
    Investigated drugs:
    Italy
  • Study of Cabozantinib and Durvalumab for Patients with Advanced Bladder Cancer After Chemotherapy

    Recruiting

    1 1 1
    Investigated drugs:
    Italy
  • Study on Bladder Cancer: Testing Cisplatin and Drug Combination for Patients with Non-Muscle Invasive Bladder Cancer

    Recruiting

    1 1 1 1
    Spain